For example, suberoylanilide hydroxamic acid (Vorinostat, SAHA, a HDAC inhibitor) and (+)-JQ1 (a BRD4 inhibitor) display an impressive efficacy against KSHV-associated lymphomas in cultured cells, animal models, and patients [10,12,13]. This evidence concerns the gene BRD4 and lymphoma.